If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksArbuthnot Regulatory News (ARBB)

Share Price Information for Arbuthnot (ARBB)

Share Price is delayed by 15 minutes
Get Live Data
825.00    5.00 (0.61%)
Bid:
825.00
Ask:
850.00
Spread: 25.00 (3.03%)
Market Cap: £134.64m
ARBB Live PriceLast checked at - London Stock Exchange

Intraday Arbuthnot Share Chart

IFRS update

14 Jul 2005 07:00

Arbuthnot Banking Group PLC14 July 2005 ARBUTHNOT BANKING GROUP PLC("Arbuthnot" or "the Group") UPDATE ON THE ADOPTION OF INTERNATIONAL FINANCIAL REPORTING STANDARDS ("IFRS") As disclosed in the 2004 Annual Report, Arbuthnot's consolidated accounts forthe reporting period ending 31 December 2005, including relevant comparativeinformation, will be prepared under IFRS. The Group has conducted a detailed review of the implications of theintroduction of IFRS for its consolidated accounts, based on those InternationalAccounting Standards and IFRS which are presently in force. The overall impact of adopting IFRS will not have a material effect on theGroup's financial position. Details of the areas impacted by the adoption ofIFRS are as follows: • The timing of recognition of some types of income differs between IFRS and UK Generally Accepted Accounting Policies ("UK GAAP"). In the year ended 31 December 2004, these timing differences would have reduced profit before tax by £100,000 and net assets by £500,000. This represents a deferral of income which, under IFRS, will be recognised in future periods. • The basis for calculating specific loan loss provisions differs between IFRS and UK GAAP. The impact in 2004 would have reduced profit before tax by £50,000 and net assets by £150,000. • Goodwill arising on past acquisitions is not amortised under IFRS but is subject to annual impairment reviews. Profit before tax and net assets under IFRS would both have increased by £200,000 in 2004. • The release of general bad debt provisions disclosed in the 2004 results amounting to £585,000 would have been reclassified as a movement on reserves under IFRS. This was a one-off item which will not recur and would have had no impact on the Group's net assets. • Under IFRS, provision is made for deferred taxation in respect of the unrealised surplus on revaluation of the Group's freehold properties. The provision at 31 December 2004 would have amounted to £1.4 million. This would have been dealt with as an adjustment to the revaluation reserve and would have had no effect on reported profits for the year. • Dividends payable are not recognised as a liability under IFRS until they are approved by shareholders. This would have had the effect of increasing the Group's net assets at 31 December 2004 by £3.0 million. 14 July 2005 Enquiries: Arbuthnot Banking Group PLC 020 7012 2400Henry Angest Chairman & CEOStephen Lockley Group Finance Director College Hill 020 7457 2020Tony FriendRichard Pearson This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
26th Jul 20181:50 pmEQSHardman & Co Research: Arbuthnot Banking Group (ARBB): 1H'18 results: continuing the good work
17th Jul 20187:00 amRNSHalf Year Report
11th Jul 20187:00 amRNSAppointment of New Chief Executive Officer
10th May 20183:26 pmRNSAGM Statement
17th Apr 20183:23 pmRNSBoard Change
4th Apr 201811:15 amRNSHardman & Co: 2017: capital deployed, adding value
28th Mar 20187:00 amRNSFinal Results
22nd Feb 20187:00 amRNSPre close Trading Update
11th Oct 20177:00 amRNSArbuthnot Banking Group 3Q Trading Update
27th Jul 201711:35 amRNSHardman Research: Value added strategy in results
18th Jul 20177:00 amRNSHalf-year Report
4th May 20173:29 pmRNSAnnual General Meeting Statement - 2017
28th Apr 201711:20 amRNSCompletion of Acquisition
30th Mar 20175:03 pmRNSDirector/PDMR Shareholding
28th Mar 20171:29 pmRNSHardman Research: History is repeating itself
23rd Mar 20177:00 amRNSFinal Results for the year to 31 December 2016
21st Feb 20177:00 amRNSPre Close Trading Update
23rd Jan 20175:58 pmRNSDirector/PDMR Shareholding
23rd Jan 20173:27 pmRNSDirector/PDMR Shareholding
22nd Dec 201612:26 pmRNSHardman Research: Clear strategy, value added deal
20th Dec 20165:10 pmRNSAsset Backed Finance Acquisition
19th Dec 20167:00 amRNSLoan Portfolio Acquisition
9th Dec 201611:12 amRNSChange of Adviser
18th Oct 20169:36 amRNSHardman&Co. Special dividend, accelerated investm.
13th Oct 20167:00 amRNSThird Quarter Trading Update
6th Oct 20162:53 pmRNSAppointment of Independent Non-Executive Director
1st Aug 20163:22 pmRNSH&Co: Tripedalism - three legs are better than two
19th Jul 20167:00 amRNSResults for the six months to 30 June 2016
1st Jul 20164:40 pmRNSSecond Price Monitoring Extn
1st Jul 20164:35 pmRNSPrice Monitoring Extension
17th Jun 201610:45 amRNSDeclaration of a Special Interim Dividend
17th Jun 201610:45 amRNSDeclaration of a Special Interim Dividend
15th Jun 20165:36 pmRNSHolding(s) in Company
15th Jun 20165:22 pmRNSCompletion of sale by Arbuthnot Banking Group PLC
15th Jun 20165:16 pmRNSCompletion of sale
14th Jun 20165:06 pmRNSPhantom Share Option Scheme
14th Jun 201611:16 amRNSResults of General Meeting
10th Jun 20162:51 pmRNSAcqusition of West End Premises
10th Jun 201610:46 amRNSAnnouncement of New Independent NED
27th May 20164:30 pmRNSConditional sale of shares by Arbuthnot
27th May 20164:30 pmRNSConditional sale of shares in Secure Trust Bank
27th May 20167:00 amRNSProposed sale of ordinary shares in Secure Trust
27th May 20167:00 amRNSProposed sale by Arbuthnot of ordinary shares
5th May 20163:28 pmRNSAGM Statement
4th May 20163:20 pmRNSAGM Statement
14th Apr 20163:01 pmRNSBoard Changes
13th Apr 20163:47 pmRNSCompletion of the disposal of Everyday Loans Group
29th Mar 20163:58 pmRNSShare Purchase
21st Mar 20161:43 pmRNSShare Acquisition
17th Mar 20167:00 amRNSFinal Results for the year to 31 December 2015

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.